Mechanisms of tissue uptake and retention of paclitaxel-coated balloons: impact on neointimal proliferation and healing

JF Granada, M Stenoien, PP Buszman, A Tellez… - Open …, 2014 - openheart.bmj.com
Background The efficacy of paclitaxel-coated balloons (PCB) for restenosis prevention has
been demonstrated in humans. However, the mechanism of action for sustained drug …

Evaluation of efficacy and dose response of different paclitaxel-coated balloon formulations in a novel swine model of iliofemoral in-stent restenosis

K Milewski, ME Afari, A Tellez, MS Aboodi… - JACC: Cardiovascular …, 2012 - jacc.org
Objectives: The authors aimed to validate a novel iliofemoral in-stent restenosis (ISR) model
for the efficacy evaluation of paclitaxel-coated balloons (PCB) using the familial …

Evaluation of a novel bioprosthetic heart valve incorporating anticalcification and antimicrobial technology in a sheep model.

D Langanki, MF Ogle, JD Cameron… - The Journal of heart …, 1998 - europepmc.org
Methods A 20-week juvenile sheep mitral valve implant model was used to determine safety
and efficacy of the device, as well as the rate of silver release and degree of dystrophic …

PATTERNS OF VASCULAR HEALING OF BARE METAL STENTS DILATED WITH A SECOND GENERATION PACLITAXEL COATED BALLOON: A COMPARATIVE …

P Buszman, A Tellez, M Afari, Y Cheng… - Journal of the American …, 2012 - jacc.org
Results At follow up angiographic % DS was significantly reduced in both study and
reference group when compared to control (PCB-BMS: 9.5± 16.4 vs. PES …